US Patent 11389439 Treatment and prevention of ocular neurodegenerative disorder
Patent 11389439 was granted and assigned to The Jackson Laboratory on July, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11389439 Treatment and prevention of ocular neurodegenerative disorder
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.